Defense Industry Daily Logo
Inmarsat to Demonstrate Space-Based BGAN Terminal

DTRA Researching Hemorrhagic Fever Anti-Viral Compounds

Ebola patient Significant progress at AVI Biopharma? (Aug 22/10) The Defense Threat Reduction Agency at Fort Belvoir, VA is awarding contracts to find new anti-viral compounds that are effective against hemorrhagic fever viruses, a class that includes Ebola and other...